We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
MC2 Therapeutics on Tuesday announced that its investigational psoriasis cream MC2-01 (calcipotriene/betamethasone) demonstrated "significant superiority" in a Phase III trial in terms of both treatment......